Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eni SpA (E) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Eni SpA vs Vaxcyte Inc. Common Stock — how do they compare? Eni SpA trades at $58.97 (market cap $82.04B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Eni SpA is far larger — about 7.8× Vaxcyte Inc. Common Stock's market cap, and Eni SpA pays a 4.25% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eni SpA for 53 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

EPCVX
Market Cap
$82.04B$10.51B
Volume
245,0932,644,694
Sector
EnergyHealth
52-Week High
$57.71$73.82
52-Week Low
$34.20$40.32
Typical Hold Time
53 Days0 Days
Enterprise Value
$106.48B$9.14B
Dividend Yield
4.25%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eni SpA

Eni (E) trades at $57.71, up 1.66% today, with strong technical momentum and bullish moving average signals. The stock shows attractive valuation metrics with P/E of 13.35 and P/S of 0.88, though recent earnings missed expectations in Q1 and Q2 2026. Revenue has declined from $132.5B in 2022 to $82.2B in 2025, but net income margin improved to 5.97% in 2026 projections. Recent developments include expansion in Venezuela oil opportunities and humanoid robotics partnerships.

The outlook remains cautiously optimistic with 34.6% analyst buy ratings and improving profitability margins. Key opportunities include Venezuela oil expansion and cost discipline, while risks involve revenue volatility and execution challenges. The stock presents value characteristics with reasonable valuation, though investors should monitor earnings consistency and global energy market conditions.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

E
100% Buy0% Sell
Avg holding period · 53 Days
PCVX
100% Buy0% Sell
Avg holding period · 0 Days

About Eni SpA

Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude

Read more on E →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →